Osocimab (BAY-1213790)

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 12:18, 23 June 2024 by Warner-admin (talk | contribs) (Text replacement - "http://www.ncbi.nlm.nih.gov/pmc" to "https://www.ncbi.nlm.nih.gov/pmc")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Mechanism of action

Anti-Factor XIa antibody

Preliminary data

Venous thromboembolism

  1. FOXTROT: Weitz JI, Bauersachs R, Becker B, Berkowitz SD, Freitas MCS, Lassen MR, Metzig C, Raskob GE. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial. JAMA. 2020 Jan 14;323(2):130-139. link to original article link to PMC article PubMed

Also known as

  • Code name: BAY-1213790
Retrieved from "https://hemonc.org/w/index.php?title=Osocimab_(BAY-1213790)&oldid=86402"